SG
Sarah Gheuens sold $296K of AGIO stock
Sarah Gheuens, Chief Medical Officer of Agios Pharmaceuticals, Inc. (AGIO), sold 7,866 shares of AGIO stock worth $296K, per an SEC Form 4 filed Oct 28, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Oct 26, 2026, 2 days before it was made public.
AGIO has moved -25.1% since the trade date, from $36.85 to $27.60 (Nov 20, 2026 close).
- Traded
- Oct 26, 2026
- Disclosed
- Oct 28, 2026
- Filing delay
- 2 days
- Price since
- -25.1%
- Role
- Chief Medical Officer
- Source
- SEC Form 4